Irazu Oncology is a verified, high-potential biotech startup based in the University of Maryland BioPark, led by Dr. Marco Chacón (founder of Paragon Bioservices, sold for $1.2B). The company has secured over $2.6M in seed funding and is developing a novel Outer Membrane Vesicle (OMV) cancer vaccine platform. However, the submission itself is of extremely low quality, containing false claims (e.g., 'most people have used my product', 'reach: everyone') and lacking technical detail. The high score reflects the verifiable off-platform reality of the project's scientific merit, funding, and leadership, despite the poor submission.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline